RiboTask ApS


The company was founded in 2006 and it’s situated in Langeskov.

CVR no. 29 78 99 83

The company produces reagents - known as RNA and LNA - for biotechnological, diagnostic, and pharmaceutical companies, as well as the world of academic research.

The product regulates genes that can cause illness and therefore prevent the development of diseased cells. RiboTask is also the first company that concentrates on synthesising LNA-modified RNA.


The market for these products is expected to grow dramatically in the next few years - a result of research developments made of the past few years, which concerns the recognition of the RNA molecules decisive role in the processes of life.

In 2009 SVD sold their shares to the company.

RiboTask Management


Suzy Lena Wengel
CEO, RiboTask ApS